Navigation Links
AirLife™ Empty Nebulizers and Heaters

ProductsAirLife™ Empty Nebulizers and Heaters
Company Cardinal Health, Inc.
Item AirLife™ Empty Nebulizers and Heaters
Features 
  • Nebulizer W/HTR ADPTR
  • Empty
  • W/AIR ENT 35%-100%
  • FIO2
  • 24 per case
  • Regulated Prod: Prescription Device
  • Latex Info: Latex free
  • Sterile: No Nebulizer EMPTY W/AIR ENT 35%-100% FIO2
Description NEBULIZER EMPTY W/AIR ENT 35%-100% FIO2

Empty Nebulizer 002002 has FIO2 settings adjustable from 35% to 100%. It has ports for a feed set and an immersion-type heater.

Empty Nebulizers 5007P and 5207 have FIO2 settings adjustable from 28% to 98%.

Convenient slip-on heaters are also available to provide heated aerosol without solution contact.
Info Cardinal Health, Inc.
Customer Service: (800) 234-8701
Web site: http://www.cardinal.com

Related medicine products :

1. AirLife™ Brand Tri-Flo® Single Catheters
2. AirLife™ Brand Tri-Flo® Cath-N-Glove® Economy Suction Kits In Peel Pouch With Vinyl Gloves
3. AirLife™ Brand Cath-N-Glove® Suction Kits In Peel Pouch
4. 002434 AirLife™ Brand Misty Max 10™ Disposable Nebulizers
5. 002438 AirLife™ Brand Misty Max 10™ Disposable Nebulizers
6. AL2500 AirLife™ Prefilled Humidifier Systems
7. AirLife™ Brand Misty Max 10™ Disposable Nebulizers
8. Misty Infant Custom Nebulizers
9. 6575-504 Custom Nebulizers
10. Pediatric Custom Nebulizers
11. Thera-Mist® Nebulizers - Closed Dilution (CDN)
Bulb Direct has been selling replacement bulbs on the Internet since 1996, and we are extremely proud of our 100% satisfaction guarantee. Check out our catalog of replacement bulbs and see our discou
Bulb Direct has been selling replacement bulbs on the Internet since 1996, and we are extremely proud of our 100% satisfaction guarantee. Check out our catalog of replacement bulbs and see our discou
...s, Ela presents the most advanced technology on th...take your patients further, offering fast follow-u... monitoring. ELA dual chamber pacemakers are also...des in patients who may benefit from maintenance o...
With the Symphony family of Pacemakers, Ela presents the most advanced technology on the market. Symphony, lighter than a passport, will take your patients further, offering fast follow-up, using new
Medicine Products:
(Date:7/25/2008)...ond quarter financial results -, LAVAL, QC, July ...DS;,NASDAQ: DDSS) today announced that it will hos...m. (ET) to discuss its second quarter 2008,financi...er 2008 financial,results via news release at appr...conference call by telephone, dial 416-646-3095 or...
(Date:7/25/2008)... /PRNewswire-FirstCall/ -- Thoratec,Corporation (N...anical,circulatory support therapies to save, supp...at it will report its operating results for the se...n Thursday, July 31., The company will hold a con...operating activities to all interested parties at ...
(Date:7/25/2008)...s reduces lung function, increases asthma risk, st...thDay News) -- A clean, fresh-smelling home may ac...ype of cleaning and air freshening products you us...cleaning products or air fresheners that contain a...4 dicholorobenzene (1,4 DCB), can reduce lung func...
(Date:7/25/2008)...8 The American Society for Gastrointestinal Endo...endoscopy in the bariatric surgery patient. The ri...d the success in surgical interventions led to a m...ies performed in the U.S., from 13,365 in 1998 to ...in the preoperative patient and the postoperative ...
Breaking Medicine News(10 mins):Health News:Labopharm to host conference call Friday, August 8, 2008 at 8:30 A.M. (ET) 2Health News:Thoratec Schedules Second Quarter 2008 Conference Call, Webcast 2Health News:Health Hazards in Household Cleaners Exposed 2Health News:Health Hazards in Household Cleaners Exposed 3Health News:ASGE issues guidelines on the role of endoscopy in the bariatric surgery patient 2Health News:ASGE issues guidelines on the role of endoscopy in the bariatric surgery patient 3
... the hormone progestin is taken as a part of hormo..., deficits in hearing sensitivity and auditory spe...ng to a research team at the Rochester School of M...The researchers found problems in the inner ear an...
...be aware of the dangers of overusing the opium-bas...le should consult their pharmacist before taking p...ceutical Union (IPU). “These medicines, which ar...our pharmacist, are very effective in relieving th...
...identified key compounds that stimulate stem cell ...ings, is set to appear in the September 2006 issue...ht one day lead to restored function for people wh...inson's, strokes, multiple sclerosis, and a wide r...
... of the International Obesity Task Force, has blam...or the obesity epidemic in poor countries. "The t... which subsidize and distort the market to make fa...egetables more expensive," James said at the 10th ...
Other Medicine News:Health News:Hearing May be affected by Certain Hormone Replacement Therapies 2Health News:Codeine-based painkillers to be used cautiously 2
(Date:7/23/2008)...l/ -- Dendreon Corporation,(Nasdaq: DNDN ) today ...itoring Committee (IDMC) to review in October 2008... to the Company,s Phase 3 IMPACT (IMmunotherapy,fo... D9902B) clinical trial,of PROVENGE(R) (sipuleucel...ive cellular immunotherapy for the treatment of ad...
(Date:7/22/2008)...lopment Initiative bring MJFF,s,current active ind...20,2009, NEW YORK, July 22 /PRNewswire-USNewswir...transformative treatments and a cure for Parkinson...inson,s Research has awarded,$2.7 million in total...s,were granted under MJFF,s Therapeutics Developme...
(Date:7/22/2008)...ortance to Patients of Passing a F...a., July 22 /- Insmed Inc. ...cs and biopharmaceuticals, today,announced that Ge...t a,Congressional briefing on Friday, July 25th, 2...ng an approval pathway for follow-on,biologics (FO...
(Date:7/22/2008)...Newswire-FirstCall/ -- NicOx S.A.,(Euronext Paris:...d the,enrollment of 417 osteoarthritis (OA) patien...armacology studies in the United States, in line w...re designed to assess the,blood pressure profile o...oxen, using the Ambulatory Blood Pressure Monitori...
Breaking Medicine Technology:Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 2Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 3Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 4Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 2Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 3Insmed CEO to Present at Congressional Briefing on Follow-On Biologics 2Insmed CEO to Present at Congressional Briefing on Follow-On Biologics 3NicOx Completes Enrollment of Two Ambulatory Blood Pressure Measurement (ABPM) Studies for Naproxcinod in Hypertensive OA Patients 2NicOx Completes Enrollment of Two Ambulatory Blood Pressure Measurement (ABPM) Studies for Naproxcinod in Hypertensive OA Patients 3Study confirms that low calorie sweeteners are helpful in weight control 2164 1Study confirms that low calorie sweeteners are helpful in weight control 2164 2Study confirms that low calorie sweeteners are helpful in weight control 2164 3GM canola ban 26quot 3Bdisappointing 26quot 3B 2162 1GM canola ban 26quot 3Bdisappointing 26quot 3B 2162 2ECNP launches research grant for young scientists 11399 119th Annual Casino Night Benefiting the National Kidney Foundation of the National Capital Area 11396 1